Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Weiss

Showing results (111-120 of 171) with videos related to

Pageof 18
Sort By:
Annals of Surgery|January 24, 2020
Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact PrognosisXu-Feng Zhang, Feng Xue, Ding-Hui Dong, et al.
Annals of Surgical Oncology|March 12, 2021
Defining the Risk of Early Recurrence Following Curative-Intent Resection for Distal CholangiocarcinomaKota Sahara, Diamantis I Tsilimigras, Junya Toyoda, et al.
Cell Chemical Biology|April 18, 2025
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancersNicholas Kwiatkowski, Tong Liang, Zhe Sha, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 22, 2017
Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysisBradley N Reames, Fabio Bagante, Aslam Ejaz, et al.
Annals of Surgical Oncology|August 27, 2022
Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize RecurrenceLaura Alaimo, Zorays Moazzam, Zachary J Brown, et al.
Annals of Surgical Oncology|November 16, 2022
Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic CholangiocarcinomaLaura Alaimo, Zorays Moazzam, Yutaka Endo, et al.
Journal of Surgical Oncology|August 14, 2024
Preoperative platelet count as an independent predictor of long-term outcomes among patients undergoing resection for intrahepatic cholangiocarcinomaOdysseas P Chatzipanagiotou, Diamantis I Tsilimigras, Giovanni Catalano, et al.
Journal of Surgical Oncology|September 17, 2024
Development and Validation of a Predictive Risk Score for Blood Transfusion in Patients Undergoing Curative-Intent Surgery for Intrahepatic CholangiocarcinomaGiovanni Catalano, Laura Alaimo, Yutaka Endo, et al.
Journal of Surgical Oncology|August 8, 2018
Preoperative prognostic nutritional index predicts survival of patients with intrahepatic cholangiocarcinoma after curative resectionÖzgür Akgül, Fabio Bagante, Griffin Olsen, et al.
Surgery|June 16, 2018
The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinomaStefan Buettner, Gaya Spolverato, Charles W Kimbrough, et al.
Pageof 18

Showing results (111-120 of 171) with videos related to

Sort By:
Pageof 18
Annals of Surgery|January 24, 2020
Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact PrognosisXu-Feng Zhang, Feng Xue, Ding-Hui Dong, et al.
Annals of Surgical Oncology|March 12, 2021
Defining the Risk of Early Recurrence Following Curative-Intent Resection for Distal CholangiocarcinomaKota Sahara, Diamantis I Tsilimigras, Junya Toyoda, et al.
Cell Chemical Biology|April 18, 2025
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancersNicholas Kwiatkowski, Tong Liang, Zhe Sha, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 22, 2017
Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysisBradley N Reames, Fabio Bagante, Aslam Ejaz, et al.
Annals of Surgical Oncology|August 27, 2022
Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize RecurrenceLaura Alaimo, Zorays Moazzam, Zachary J Brown, et al.
Annals of Surgical Oncology|November 16, 2022
Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic CholangiocarcinomaLaura Alaimo, Zorays Moazzam, Yutaka Endo, et al.
Journal of Surgical Oncology|August 14, 2024
Preoperative platelet count as an independent predictor of long-term outcomes among patients undergoing resection for intrahepatic cholangiocarcinomaOdysseas P Chatzipanagiotou, Diamantis I Tsilimigras, Giovanni Catalano, et al.
Journal of Surgical Oncology|September 17, 2024
Development and Validation of a Predictive Risk Score for Blood Transfusion in Patients Undergoing Curative-Intent Surgery for Intrahepatic CholangiocarcinomaGiovanni Catalano, Laura Alaimo, Yutaka Endo, et al.
Journal of Surgical Oncology|August 8, 2018
Preoperative prognostic nutritional index predicts survival of patients with intrahepatic cholangiocarcinoma after curative resectionÖzgür Akgül, Fabio Bagante, Griffin Olsen, et al.
Surgery|June 16, 2018
The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinomaStefan Buettner, Gaya Spolverato, Charles W Kimbrough, et al.
Pageof 18